AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9455717 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam with Erythromycin
Number of subjects: 0
Study 9455717 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam with Clarithromycin
Number of subjects: 0
Study 9455717 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam with Azithromycin
Number of subjects: 0
Study 9455717 — intervention group
Group type: COMPARATOR
Intervention: Midazolam with Erythromycin or Clarithromycin
Number of subjects: 0
Study 8187005 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional four cycles of vinblastine/cisplatin after radiotherapy
Number of subjects: 91
Study 8187005 — intervention group
Group type: EXPERIMENTAL
Intervention: Six weekly doses of carboplatin concurrent with radiotherapy
Number of subjects: 91
Study 3063506 — intervention group
Group type: EXPERIMENTAL
Intervention: Acebutolol
Number of subjects: 0
Study 3063506 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 0
Study 31115690 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapapillary injection (IPI)
Number of subjects: 40
Study 31115690 — intervention group
Group type: COMPARATOR
Intervention: Inferior alveolar nerve block (IANB)
Number of subjects: 40
Study 31115690 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IPI and IANB
Number of subjects: 40
Study 31573398 — intervention group
Group type: COMPARATOR
Intervention: 0.55 T MRI examinations
Number of subjects: 83
Study 31573398 — intervention group
Group type: COMPARATOR
Intervention: 0.55 T MRI with metallic interventional devices
Number of subjects: 83
Study 31573398 — intervention group
Group type: COMPARATOR
Intervention: MRI-guided right heart catheterization
Number of subjects: 83
Study 31573398 — intervention group
Group type: COMPARATOR
Intervention: Oxygen inhalation during 0.55 T MRI
Number of subjects: 83
Study 31573398 — intervention group
Group type: COMPARATOR
Intervention: Spiral image acquisitions at 0.55 T
Number of subjects: 83
Study 31573398 — intervention group
Group type: COMPARATOR
Intervention: Representative imaging of brain, spine, abdomen, and heart at 0.55 T
Number of subjects: 83
Study 28516509 — intervention group
Group type: EXPERIMENTAL
Intervention: Subthreshold depression (CES-D)
Number of subjects: 540
Study 28516509 — intervention group
Group type: EXPERIMENTAL
Intervention: Subthreshold anxiety (HADS-A)
Number of subjects: 540
Study 25929711 — intervention group
Group type: EXPERIMENTAL
Intervention: Chin cup treatment
Number of subjects: 42
Study 25929711 — intervention group
Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 42
Study 23521503 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK239512 (5/10/20/40 μg and 10/20/40/80 μg regimens)
Number of subjects: 18
Study 23521503 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK239512 (20/40/80/150 μg regimen)
Number of subjects: 18
Study 23521503 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in Part A and Part B)
Number of subjects: 18
Study 21269308 — intervention group
Group type: EXPERIMENTAL
Intervention: LAB diet
Number of subjects: 34
Study 21269308 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 19761874 — intervention group
Group type: EXPERIMENTAL
Intervention: RMET
Number of subjects: 26
Study 19761874 — intervention group
Group type: EXPERIMENTAL
Intervention: IMT
Number of subjects: 26
Study 19761874 — intervention group
Group type: COMPARATOR
Intervention: Sham-training
Number of subjects: 26
Study 16875470 — intervention group
Group type: EXPERIMENTAL
Intervention: Contractubex gel
Number of subjects: 120
Study 16875470 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Contractubex gel)
Number of subjects: 120
Study 15211871 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperthermia
Number of subjects: 0
Study 11418912 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro QuickAnchor (1.3 mm) using 3‐0 braided polyester with a modified 4‐strand Becker suture pattern
Number of subjects: 9
Study 11418912 — intervention group
Group type: COMPARATOR
Intervention: Pullout button using 3‐0 monofilament nylon in a 2‐strand Bunnell suture pattern
Number of subjects: 9
Study 11418912 — intervention group
Group type: COMPARATOR
Intervention: Mini QuickAnchor (1.8 mm) using 3‐0 braided polyester in a 2‐strand Bunnell suture pattern
Number of subjects: 9
Study 9024032 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural dexamethasone (1 mL, 5 mg) with 25 mL 2% lidocaine and epinephrine 1:200,000
Number of subjects: 1000
Study 9024032 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group II) - no dexamethasone
Number of subjects: 1000
Study 8395488 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose Lisinopril
Number of subjects: 16
Study 8395488 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 3740389 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine applied topically to the fallopian tubes and injected into the skin wounds
Number of subjects: 60
Study 3740389 — intervention group
Group type: COMPARATOR
Intervention: No local anaesthetic (Control)
Number of subjects: 60
Study 3740389 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 30412993 — intervention group
Group type: EXPERIMENTAL
Intervention: Nature-Based Therapy (NBT)
Number of subjects: 20
Study 30412993 — intervention group
Group type: COMPARATOR
Intervention: Support Group Meetings (SGMs)
Number of subjects: 20
Study 26154154 — intervention group
Group type: EXPERIMENTAL
Intervention: Vascular occlusion (OCC)
Number of subjects: 12
Study 26154154 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential intermittent pneumatic compression (SIPC)
Number of subjects: 12
Study 26154154 — intervention group
Group type: COMPARATOR
Intervention: Passive control (CON)
Number of subjects: 12
Study 26154154 — intervention group
Group type: EXPERIMENTAL
Intervention: All conditions (OCC, SIPC, CON)
Number of subjects: 12
Study 24473249 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythmic auditory-cued (RAC) overground walking
Number of subjects: 20
Study 24473249 — intervention group
Group type: EXPERIMENTAL
Intervention: Speed-dependent treadmill training (SDTT)
Number of subjects: 20
Study 24473249 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 20
Study 22019076 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (10-20mg/day, n=169)
Number of subjects: 343
Study 22019076 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine (300-700mg/day, n=174)
Number of subjects: 343
Study 22019076 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Olanzapine and Quetiapine
Number of subjects: 343
Study 19827029 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% extract of Solidago chilensis applied externally as a gel, two daily applications for 15 days
Number of subjects: 10
Study 19827029 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel applied externally, two daily applications for 15 days
Number of subjects: 10
Study 17823508 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular dentifrices (1,500 ppm F)
Number of subjects: 42
Study 17823508 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavoured dentifrices for children (1,100 ppm F)
Number of subjects: 42
Study 15775780 — intervention group
Group type: EXPERIMENTAL
Intervention: NOS3 haplotypes
Number of subjects: 110
Study 15775780 — intervention group
Group type: EXPERIMENTAL
Intervention: Four haplotypes accounting for 11.9% of all represented haplotypes
Number of subjects: 110
Study 11975091 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine (2 x 2 mg)
Number of subjects: 24
Study 11975091 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 11471032 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha‐IFN treatment
Number of subjects: 261
Study 11471032 — intervention group
Group type: COMPARATOR
Intervention: Control group (adults)
Number of subjects: 261
Study 8732235 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarosan treatment and bedding covers
Number of subjects: 70
Study 8732235 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 70
Study 8732235 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarosan treatment
Number of subjects: 70
Study 1374201 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac (0.35 mg.kg‐1 bolus followed by a constant‐rate infusion of 90 micrograms.min‐1 for 24 h)
Number of subjects: 40
Study 1374201 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 1374201 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 40
Study 3926667 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg dexamethasone (1 ml Decadronphosphate)
Number of subjects: 30
Study 3926667 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 31959019 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine HFA (2 × 125 mcg/inhalation)
Number of subjects: 0
Study 31959019 — intervention group
Group type: COMPARATOR
Intervention: Epinephrine CFC (2 × 220 mcg/inhalation)
Number of subjects: 0
Study 31959019 — intervention group
Group type: COMPARATOR
Intervention: Placebo HFA
Number of subjects: 0
Study 30770780 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MP) 0.5 mg/kg, i.v.
Number of subjects: 46
Study 30770780 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 46
Study 30770780 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MP)
Number of subjects: 46
Study 29158148 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 57
Study 29158148 — intervention group
Group type: COMPARATOR
Intervention: Sertraline
Number of subjects: 57
Study 27269942 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertuzumab (840 mg loading dose followed by 420 mg every 3 weeks)
Number of subjects: 156
Study 27269942 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study 27269942 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertuzumab plus chemotherapy
Number of subjects: 156
Study 27269942 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine and paclitaxel cohorts
Number of subjects: 156
Study 24198302 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2605541
Number of subjects: 76
Study 24198302 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 76
Study 22873700 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity intervention
Number of subjects: 0
Study 22873700 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity intervention
Number of subjects: 0
Study 22873700 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 20383089 — intervention group
Group type: EXPERIMENTAL
Intervention: Reviewing the video and 10 minutes unsupervised practice
Number of subjects: 55
Study 20383089 — intervention group
Group type: COMPARATOR
Intervention: Control group (received the intervention after the scenario)
Number of subjects: 55
Study 18405704 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetal pulmonary artery (PA) diameters measurement
Number of subjects: 21
Study 16472719 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol ingestion (60 g of ethanol)
Number of subjects: 100
Study 16472719 — intervention group
Group type: COMPARATOR
Intervention: Nonalcoholic beverage (control)
Number of subjects: 100
Study 12661144 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile tocolysis with Fenoterol
Number of subjects: 24
Study 12661144 — intervention group
Group type: COMPARATOR
Intervention: Continuous tocolysis with Fenoterol
Number of subjects: 24
Study 10235107 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (1 mg)
Number of subjects: 0
Study 10235107 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8918401 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral levo-leucovorin (1-leucovorin) 25 mg/dose followed by oral 5-dFUR 750 mg/m2 twice daily for 4 days every 12 days (arm A)
Number of subjects: 130
Study 8918401 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous (i.v.) 1-leucovorin 25 mg/dose followed by i.v. 5-dFUR 3000 mg/m2 for 5 days every 21 days (arm B)
Number of subjects: 130
Study 31451014 — intervention group
Group type: EXPERIMENTAL
Intervention: SYNERGY
Number of subjects: 1684
Study 31451014 — intervention group
Group type: COMPARATOR
Intervention: PROMUS Element Plus
Number of subjects: 1684
Study 31451014 — intervention group
Group type: EXPERIMENTAL
Intervention: SYNERGY (Diabetes Substudy)
Number of subjects: 1684
Study 31451014 — intervention group
Group type: COMPARATOR
Intervention: PROMUS Element Plus (Diabetes Substudy)
Number of subjects: 1684
Study 28106568 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Therapy (PT)
Number of subjects: 2
Study 28106568 — intervention group
Group type: COMPARATOR
Intervention: General Exercise (GE)
Number of subjects: 2
Study 26229109 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint mobilization and stretching exercises
Number of subjects: 30
Study 26229109 — intervention group
Group type: COMPARATOR
Intervention: Stretching exercises alone
Number of subjects: 30
Study 24468068 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymmetric training program using virtual reality reflection equipment
Number of subjects: 24
Study 24468068 — intervention group
Group type: COMPARATOR
Intervention: Symmetric training program
Number of subjects: 24
Study 23077192 — intervention group
Group type: EXPERIMENTAL
Intervention: Skim milk
Number of subjects: 203
Study 23077192 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey
Number of subjects: 203
Study 23077192 — intervention group
Group type: EXPERIMENTAL
Intervention: Casein
Number of subjects: 203
Study 23077192 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 203
Study 23077192 — intervention group
Group type: COMPARATOR
Intervention: Pretest control group
Number of subjects: 203
Study 18955429 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative physiotherapy
Number of subjects: 23
Study 18955429 — intervention group
Group type: COMPARATOR
Intervention: Control group (no pre-operative physiotherapy)
Number of subjects: 23
Study 15725200 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwife-led brief counseling intervention (face-to-face within 72 hours of birth and telephone at 4-6 weeks postpartum)
Number of subjects: 103
Study 15725200 — intervention group
Group type: COMPARATOR
Intervention: Control group (no counseling intervention)
Number of subjects: 103
Study 12733954 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral Moore pharyngoplasty
Number of subjects: 18
Study 11401042 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple chronic health problems (categories: 'No', 'Few', 'Some', 'A lot of')
Number of subjects: 4000
Study 11401042 — intervention group
Group type: EXPERIMENTAL
Intervention: Low income and unemployment
Number of subjects: 4000
Study 11401042 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 4000
Study 8971943 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-coated ECC
Number of subjects: 200
Study 8971943 — intervention group
Group type: COMPARATOR
Intervention: Uncoated ECC
Number of subjects: 200
Study 1290729 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen SR
Number of subjects: 80
Study 1290729 — intervention group
Group type: COMPARATOR
Intervention: Sulindac
Number of subjects: 80
Study 2981515 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent long-term combined chemotherapy (ILTCC) with immunotherapy
Number of subjects: 0
Study 2981515 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous long-term combined chemotherapy (CLTCC) with immunotherapy
Number of subjects: 0
Study 2981515 — intervention group
Group type: COMPARATOR
Intervention: Short-term combined chemotherapy (STCC)
Number of subjects: 0
Study 30978434 — intervention group
Group type: EXPERIMENTAL
Intervention: Infused autograft immune effector cells (macrophage type 1, macrophage type 2, dendritic cell type 1, dendritic cell type 2, myeloid-derived suppressor cells, CD4+PD-1-, CD4+PD-1+, CD8+PD-1-, CD8+PD-1+, lymphocyte to monocyte ratio, NKp30, KIR2DL2)
Number of subjects: 111
Study 30978434 — intervention group
Group type: EXPERIMENTAL
Intervention: A-LMR, MDSC, NKp30, KIR2DL2, lactate dehydrogenase
Number of subjects: 111
Study 30978434 — intervention group
Group type: EXPERIMENTAL
Intervention: DC1, MDSC, NKp30, CD4+PD-1-, M2
Number of subjects: 111
Study 29332737 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral glide MWM of the hip joint into flexion
Number of subjects: 15
Study 29332737 — intervention group
Group type: COMPARATOR
Intervention: Placebo MWM
Number of subjects: 15
Study 29332737 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 15
Study 27422283 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 746
Study 27422283 — intervention group
Group type: EXPERIMENTAL
Intervention: Training and support
Number of subjects: 746
Study 27422283 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial reimbursement
Number of subjects: 746
Study 27422283 — intervention group
Group type: EXPERIMENTAL
Intervention: Opportunity to refer patients to an internet-based brief intervention (e-BI)
Number of subjects: 746
Study 27422283 — intervention group
Group type: EXPERIMENTAL
Intervention: Paired combinations of strategies
Number of subjects: 746
Study 27422283 — intervention group
Group type: EXPERIMENTAL
Intervention: All three strategies combined
Number of subjects: 746
Study 23263261 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised medical exercise therapy
Number of subjects: 70
Study 23263261 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 70
Study 22976739 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (3 days/week, 50 min/day for 12 weeks)
Number of subjects: 22
Study 22976739 — intervention group
Group type: COMPARATOR
Intervention: Control (physical education activities)
Number of subjects: 22
Study 21309475 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole (20 mg/day) in healthy subjects
Number of subjects: 104
Study 21309475 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel plus aspirin
Number of subjects: 104
Study 21309475 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole (20 mg/day) in patients with a stent
Number of subjects: 104
Study 17274713 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine HCl with 1:100,000 epinephrine (A100)
Number of subjects: 42
Study 17274713 — intervention group
Group type: COMPARATOR
Intervention: 4% articaine HCl with 1:200,000 epinephrine (A200)
Number of subjects: 42
Study 16171434 — intervention group
Group type: EXPERIMENTAL
Intervention: CHX (0.12% chlorhexidine digluconate)
Number of subjects: 30
Study 16171434 — intervention group
Group type: EXPERIMENTAL
Intervention: CHX + 0.05% sodium fluoride (CHXNaF)
Number of subjects: 30
Study 16171434 — intervention group
Group type: EXPERIMENTAL
Intervention: CHX + 0.05% cetylpyridinium chloride (CHX-CPC)
Number of subjects: 30
Study 12736845 — intervention group
Group type: EXPERIMENTAL
Intervention: Women (n=24)
Number of subjects: 35
Study 12736845 — intervention group
Group type: COMPARATOR
Intervention: Men (n=11)
Number of subjects: 35
Study 12736845 — intervention group
Group type: EXPERIMENTAL
Intervention: Office assistants (n=6 women)
Number of subjects: 35
Study 10539831 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg/d tranilast
Number of subjects: 255
Study 10539831 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg/d tranilast
Number of subjects: 255
Study 10539831 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 255
Study 8557899 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (200 mg once daily)
Number of subjects: 280
Study 8557899 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg twice daily)
Number of subjects: 280
Study 8557899 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (metoprolol + nifedipine)
Number of subjects: 280
Study 8557899 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine added to metoprolol
Number of subjects: 280
Study 8557899 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol added to nifedipine
Number of subjects: 280
Study 1817760 — intervention group
Group type: EXPERIMENTAL
Intervention: Gallopamil sustained release (SR)
Number of subjects: 0
Study 1817760 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6285406 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/kg CBD
Number of subjects: 8
Study 6285406 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg delta 9‐THC
Number of subjects: 8
Study 6285406 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixture of 0.5 mg/kg delta 9‐THC and 1 mg/kg CBD
Number of subjects: 8
Study 6285406 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 6285406 — intervention group
Group type: COMPARATOR
Intervention: 10 mg diazepam
Number of subjects: 8
Study 30176872 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib with anti-acid medication
Number of subjects: 1061
Study 30176872 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib without anti-acid medication
Number of subjects: 1061
Study 30176872 — intervention group
Group type: COMPARATOR
Intervention: Placebo with anti-acid medication
Number of subjects: 1061
Study 30176872 — intervention group
Group type: COMPARATOR
Intervention: Placebo without anti-acid medication
Number of subjects: 1061
Study 27160359 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus (EVR)
Number of subjects: 81
Study 27160359 — intervention group
Group type: COMPARATOR
Intervention: Calcineurin inhibitor (CNI)
Number of subjects: 81
Study 24830749 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily Co-trimoxazole (CTX)
Number of subjects: 346
Study 24830749 — intervention group
Group type: COMPARATOR
Intervention: Sulfadoxine‐pyrimethamine (SP)
Number of subjects: 346
Study 22354934 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin monotherapy
Number of subjects: 2179
Study 22354934 — intervention group
Group type: COMPARATOR
Intervention: Heparin plus a GPI
Number of subjects: 2179
Study 22354934 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline troponin elevation
Number of subjects: 2179